Evidence map›Paper›PMID 23978545›Full record

ReviewAdvances in chronic kidney disease2013

Women, kidney disease, and pregnancy.

Andrew Smyth, Milan Radovic, Vesna D Garovic

Open access · bronzeAbstract readReview
In one paragraph

Review in Advances in chronic kidney disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Kidney diseases in women: difference in risks and opportunities.Revista da Associacao Medica Brasileira (1992) · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Fetal Risks and Maternal Renal Complications in Pregnancy with Preexisting Chronic Glomerulonephritis.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Andrew SmythHRB Clinical Research Facility Galway, NUI, Galway, Ireland.
Milan Radovic
Vesna D Garovic
Ollscoil na Gaillimhe – University of Galway · IEUniversity of Belgrade · RS

Funding

Sex-specific Risk for Vascular Dysfunction and Cognitive DeclineP50AG044170 · NIA · MAYO CLINIC ROCHESTER · PI MILLER, VIRGINIA M · 2012 to 2017
$6.1M
VEGF Signaling in Endothelial and Glomerular Epithelial Cells in PreeclampsiaK08HD051714 · NICHD · MAYO CLINIC ROCHESTER · PI GAROVIC, VESNA D · 2008 to 2012
$637k
NIA NIH HHS P50 AG044170NIA NIH HHS P-50 AG44170NICHD NIH HHS K08 HD051714
6 · The paper itself

Abstract

Several glomerular diseases may occur in women of childbearing age. Pregnancy in such patients should be planned when the disease has been in remission for a minimum of 6 months to minimize maternal and fetal complications. Immunosuppressive agents should be optimized before conception to include those that are safe for pregnancy. The complexity of medical management when caring for these patients calls for a multidisciplinary team approach consisting of a nephrologist, rheumatologist, obstetrician, and pharmacist. This review will address the physiological changes of pregnancy that may affect glomerular disease presentation, activity, and diagnosis; specific glomerular diseases primary and secondary to systemic diseases in the context of pregnancy; fetal and maternal complications and long-term effects; diagnosis and differential diagnosis; and treatment strategies that are considered relatively safe with respect to fetal intrauterine exposure.

Indexed as

Antiphospholipid SyndromeAtypical Hemolytic Uremic SyndromeDiabetic NephropathiesFemaleGlomerulonephritisHemolytic-Uremic SyndromeHumansImmunosuppressive AgentsKidney DiseasesLupus NephritisNephrosis, LipoidPregnancyPregnancy ComplicationsScleroderma, SystemicVasculitisImmunosuppressive AgentsGlomerular diseaseKidney diseasePreeclampsiaPregnancyProteinuria

Identifiers

PMID23978545
PMCPMC3763929
OpenAlexW2081021582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.